Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NDM-1 risk underlines need for good infection control

  • 1 Comment

Nurses are being reminded of the need for extra vigilance around infection control following news of the arrival in the UK of a virulent enzyme that creates bacteria that are resistant to carbapenems - last-line antibiotics.

The Lancet Infectious Disease journal today reports that New Delhi Metallo-beta-lactamase -1 (NDM-1) which is present in 1 per cent to 3 per cent of patients in India, has been observed in 50 patients in the UK over the last three years. 

NDM-1 has been found in bacteria that can cause fatal pneumonia and urinary tract infections.

Two of the UK patients died although both also had an underlying serious illness. The other patients required long term treatment in isolation.

Some of the infected British patients had travelled to India for kidney or bone marrow transplants, dialysis, pregnancy care or burns treatment, while others had undergone cosmetic surgery such as “tummy tucks”. Previous cases have emerged in holidaymakers who picked up the bacteria while hospitalised in Greece and Turkey after a moped accident.

The Health Protection Agency says the enzyme is a “notable public health risk” and is urging vigilance.

Lancet study co-author, Dr David Livermore, director of antibiotic resistance monitoring at the HPA, said: “The findings of this paper show that resistance to one of the major groups of antibiotics, the carbapenems, is widespread in India. This is important because carbapenems were often the last ‘good’ antibiotics active against bacteria that already were resistant to more standard drugs.

“We have now also identified bacteria with this type of resistance - NDM - in around 50 patients in the UK.  Most, not all, had previously travelled to the Indian subcontinent, and many had received hospital treatment there.  International travel gives a great potential for spread of resistant bacteria between countries.

“Few antibiotics remain active against these bacteria.  Their spread underscores the need for good infection control in hospitals both in the UK and overseas, and the need for new antibiotic development.” 

  • 1 Comment

Readers' comments (1)

  • It seems a little late to highlight the reality that services available in the UK are at threat from economic tourists who seek cheaper treatments available abroad.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.